22-45414358-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015653.5(RIBC2):āc.166C>Gā(p.Gln56Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000181 in 1,550,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/15 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_015653.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIBC2 | NM_015653.5 | c.166C>G | p.Gln56Glu | missense_variant | 2/7 | ENST00000614167.2 | NP_056468.3 | |
RIBC2 | XM_017028766.2 | c.166C>G | p.Gln56Glu | missense_variant | 2/5 | XP_016884255.1 | ||
RIBC2 | XM_005261524.5 | c.-54C>G | 5_prime_UTR_variant | 2/7 | XP_005261581.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152074Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000261 AC: 4AN: 153262Hom.: 0 AF XY: 0.0000492 AC XY: 4AN XY: 81358
GnomAD4 exome AF: 0.0000164 AC: 23AN: 1398894Hom.: 0 Cov.: 31 AF XY: 0.0000217 AC XY: 15AN XY: 689962
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152074Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 31, 2024 | The c.151C>G (p.Q51E) alteration is located in exon 2 (coding exon 2) of the RIBC2 gene. This alteration results from a C to G substitution at nucleotide position 151, causing the glutamine (Q) at amino acid position 51 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at